Details
Enter the name of the Clinical Trial Site- Organisation Name: Momentum Clinical Research-Taringa, Services Offered by your site: Early Phase, Clinical trials site, GP trials, Trial Patient Recruitment, Treatment of patients, Completion of study documentation as per ICH GCP and contract, Contact person email address: , Your Clinical Trial Site website address: , Do you have Affiliated Research Sites or Satellite Sites/Clinics? : Yes, If you selected Yes for the previous question, please list where: Other Momentum sites at Brisbane, Sydney Melbourne, NZ
Location
-27.489811899907398, 152.98142737930692
Initiating study activities approval
Is your Facility able to initiate study activities prior to HREC (IRB/ERB/ETHICS) Committee protocol approval?: Yes
Site Overview
Please provide the short promotional description of your Clinical Trial Site for marketing purposes.:
HREC
What types of HREC (IRB/ERB/ETHICS) Committee does your Facility use? Select all that apply. If QH choose Central Acting as Local-For National Mutual Acceptance (NMA): Local, Does your institution and/or local regulation mandate the distribution of safety reports e.g., Development Safety Update Report (DSUR), Suspected Unexpected Serious Adverse Reaction (SUSAR) to a local review only HREC (IRB/ERB/ETHICS) Committee?: Yes, If Other was selected for the HREC Committee Name, please name here.: Bellberry HREC, What is the meeting frequency of your Local HREC Committee?: Weekly
Facility staffing and training
Does your Facility have a training program for the research staff?: No, Does the course content include GCP?: Yes, Does the study staff that prepares or transports dangerous goods have training that meets the IATA International Air Transport Association (US) or other countries hazardous training requirements for shipping dangerous goods?: Yes, Is your Facility adequately staffed to support studies with both blinded and unblinded Investigational Product?: Yes
Licenses to receive, store, dispense and return controlled substances
Does the Facility have the required licenses or registrations to receive, store, dispense and return controlled substances as required by local law?: Yes, Does the Facility have the ability to handle radio-labelled Investigational Products?: No
Equipment
Do you have centrifuge available at the Facility to support Research studies?: Yes, Do you have refrigerated centrifuge available at the Facility to support Research studies?: Yes, Please identify the Investigational Product preparation capabilities at your Facility: Extemporaneous Preparation, Horizontal laminar flow hood (non-hazardous drug preparation)
Patient Records
Does your Facility have patient record archiving on-site?: No, Do you have Electronic Health Records (EHR)/ Electronic Medical Records (EMR)?: Yes
Investigational product storage Capabilities
Do you have a refrigerator (2 to 8 Degrees C) available at the Facility to support Research studies?: Yes, Refrigerator 2 to 8 Degrees C | Do you have the ability to generate a temperature monitoring log for this equipment?: Yes, Refrigerator 2 to 8 Degrees C | Does this equipment provide Min/Max Temperature Monitoring?: Yes, Refrigerator 2 to 8 Degrees C | Does this equipment have a temperature alarm?: Yes, Refrigerator 2 to 8 Degrees C | Do you have an SOP that supports the calibration of this equipment?: Yes, Do you have a freezer (-20 to -30 Degrees C) available at the Facility to support Research studies?: Yes
Specialty Research Area
Cardiovascular Diseases
Digestive System Diseases
Endocrine System Diseases
Eye Diseases
Male Urogenital Diseases
Musculoskeletal Diseases
Nutritional and Metabolic Diseases
Parasitic Diseases
Pathological Conditions
Respiratory Tract Diseases
Signs and Symptoms
Skin and Connective Tissue Diseases
Virus Diseases
Wounds and Injuries
Study Types
Government
Industry
Investigator
Source Document Types
Electronic
Has your Clinical Trials Site or Service been audited by:
Sponsor
Average time to start study (in calendar days)
61-90
How long prior to HREC meeting does the application need to be submitted?
1 week
Does the HREC committee require contract /budget approval prior to release final approval documents?
No
Support in-patient admissions
No
PK & PD specimens
Yes
Study Phase Capability
Phase I
Phase II
Phase III
Phase IV
Type of Diagnostic Equipment
CT Scan Computerized Tomography Scan
DXA Dual-Energy X-ray Absorptiometry or Bone Densitometry
ECG/EKG Electrocardiogram
FLRO Fluoroscopy
MAMMO Mammography
MRA Magnetic Resonance Angiography
MRI Magnetic Resonance Imaging
MRS Magnetic Resonance Spectroscopy
Perfusion CT
PET Positron Emission Tomography Scan
SPECT
Thyroid scan
X-Ray
Patient Population
Adolescents/Adults 16 and onwards
Adults 18 and onwards
Geriatrics 65 and onwards